Launch 17 Jun 2024 · costs from the KID as of 14 Aug 2026 · 49 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The investment objective of the Fund is to provide exposure to the performance of the most liquid companies listed on the ChiNext market of the Shenzhen Stock Exchange ("SZSE") in China.
Redemption and Dealing of Shares:
The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in…
Performance since series start (in euro) — base 100
17 Jun 2024 → 14 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 279 (25 Jun 2026) · low 81 (27 Aug 2024) · last 223. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/IE000AWRDWI7 Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.